Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
489 | 23107 | 30.5 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CISPLATIN | authKW | 317708 | 7% | 15% | 1567 |
2 | STABILITY CONSTANTS | authKW | 125113 | 2% | 22% | 436 |
3 | JOURNAL OF INORGANIC BIOCHEMISTRY | journal | 97174 | 3% | 12% | 646 |
4 | CHEMISTRY, INORGANIC & NUCLEAR | WoSSC | 83173 | 22% | 1% | 5045 |
5 | NEPHROTOXICITY | authKW | 74445 | 2% | 13% | 433 |
6 | INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY | journal | 71098 | 1% | 25% | 219 |
7 | PLATINUM COMPLEXES | authKW | 69289 | 1% | 22% | 237 |
8 | PLATINUMII COMPLEXES | authKW | 68740 | 1% | 39% | 135 |
9 | DIPARTIMENTO CHIM INORGAN CHIM ANALIT CHIM FIS | address | 65672 | 1% | 31% | 163 |
10 | PROTONATION CONSTANTS | authKW | 53591 | 0% | 44% | 92 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Inorganic & Nuclear | 83173 | 22% | 1% | 5045 |
2 | Chemistry, Multidisciplinary | 22403 | 22% | 0% | 5121 |
3 | Oncology | 9046 | 12% | 0% | 2806 |
4 | Chemistry, Analytical | 7839 | 9% | 0% | 2144 |
5 | Pharmacology & Pharmacy | 4951 | 11% | 0% | 2548 |
6 | Chemistry, Medicinal | 3848 | 5% | 0% | 1057 |
7 | Crystallography | 3278 | 4% | 0% | 891 |
8 | Thermodynamics | 2146 | 3% | 0% | 710 |
9 | Toxicology | 1464 | 3% | 0% | 735 |
10 | Biochemistry & Molecular Biology | 1270 | 11% | 0% | 2546 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIPARTIMENTO CHIM INORGAN CHIM ANALIT CHIM FIS | 65672 | 1% | 31% | 163 |
2 | PLATINUM BASED DRUG | 21112 | 0% | 100% | 16 |
3 | HOFFMAN CHEM | 14728 | 0% | 62% | 18 |
4 | LEHRSTUHL PHARMAZEUT CHEM 2 | 14614 | 0% | 92% | 12 |
5 | JIANGSU PROV HITECH BIOMED | 12677 | 0% | 28% | 35 |
6 | CHEM | 10829 | 16% | 0% | 3793 |
7 | SERV FARMACOL TOSSICOL | 10686 | 0% | 90% | 9 |
8 | THERMODYNAM KINET CHEM PROC | 10272 | 0% | 35% | 22 |
9 | MOE MED CHEM MOL DIAGNOST | 9713 | 0% | 82% | 9 |
10 | UNIDADE RIO DE JANEIRO | 9419 | 0% | 71% | 10 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF INORGANIC BIOCHEMISTRY | 97174 | 3% | 12% | 646 |
2 | INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY | 71098 | 1% | 25% | 219 |
3 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 30791 | 2% | 6% | 418 |
4 | ANNALI DI CHIMICA | 29985 | 1% | 11% | 211 |
5 | ANALES DE QUIMICA SERIE B-QUIMICA INORGANICA Y QUIMICA ANALYTICA | 22116 | 0% | 17% | 102 |
6 | JOURNAL OF THE INDIAN CHEMICAL SOCIETY | 21565 | 2% | 4% | 397 |
7 | INORGANICA CHIMICA ACTA | 16719 | 2% | 3% | 473 |
8 | ZHURNAL NEORGANICHESKOI KHIMII | 15943 | 1% | 4% | 344 |
9 | JOURNAL OF SOLUTION CHEMISTRY | 15031 | 1% | 6% | 206 |
10 | CHEMICAL SPECIATION AND BIOAVAILABILITY | 12916 | 0% | 14% | 69 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CISPLATIN | 317708 | 7% | 15% | 1567 | Search CISPLATIN | Search CISPLATIN |
2 | STABILITY CONSTANTS | 125113 | 2% | 22% | 436 | Search STABILITY+CONSTANTS | Search STABILITY+CONSTANTS |
3 | NEPHROTOXICITY | 74445 | 2% | 13% | 433 | Search NEPHROTOXICITY | Search NEPHROTOXICITY |
4 | PLATINUM COMPLEXES | 69289 | 1% | 22% | 237 | Search PLATINUM+COMPLEXES | Search PLATINUM+COMPLEXES |
5 | PLATINUMII COMPLEXES | 68740 | 1% | 39% | 135 | Search PLATINUMII+COMPLEXES | Search PLATINUMII+COMPLEXES |
6 | PROTONATION CONSTANTS | 53591 | 0% | 44% | 92 | Search PROTONATION+CONSTANTS | Search PROTONATION+CONSTANTS |
7 | CARBOPLATIN | 37048 | 1% | 10% | 271 | Search CARBOPLATIN | Search CARBOPLATIN |
8 | TERNARY COMPLEXES | 34487 | 0% | 30% | 86 | Search TERNARY+COMPLEXES | Search TERNARY+COMPLEXES |
9 | TRANSPLATIN | 33428 | 0% | 69% | 37 | Search TRANSPLATIN | Search TRANSPLATIN |
10 | DISSOCIATION CONSTANT | 30146 | 1% | 16% | 143 | Search DISSOCIATION+CONSTANT | Search DISSOCIATION+CONSTANT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JOHNSTONE, TC , SUNTHARALINGAM, K , LIPPARD, SJ , (2016) THE NEXT GENERATION OF PLATINUM DRUGS: TARGETED PT(II) AGENTS, NANOPARTICLE DELIVERY, AND PT(IV) PRODRUGS.CHEMICAL REVIEWS. VOL. 116. ISSUE 5. P. 3436 -3486 | 303 | 62% | 56 |
2 | WILSON, JJ , LIPPARD, SJ , (2014) SYNTHETIC METHODS FOR THE PREPARATION OF PLATINUM ANTICANCER COMPLEXES.CHEMICAL REVIEWS. VOL. 114. ISSUE 8. P. 4470 -4495 | 244 | 77% | 100 |
3 | OUN, R , WHEATE, NJ , WALKER, S , CRAIG, GE , (2010) THE STATUS OF PLATINUM ANTICANCER DRUGS IN THE CLINIC AND IN CLINICAL TRIALS.DALTON TRANSACTIONS. VOL. 39. ISSUE 35. P. 8113 -8127 | 136 | 74% | 474 |
4 | WONG, E , GIANDOMENICO, CM , (1999) CURRENT STATUS OF PLATINUM-BASED ANTITUMOR DRUGS.CHEMICAL REVIEWS. VOL. 99. ISSUE 9. P. 2451 -2466 | 138 | 87% | 1303 |
5 | JAKUPEC, MA , GALANSKI, M , KEPPLER, BK , (2003) TUMOUR-INHIBITING PLATINUM COMPLEXES-STATE OF THE ART AND FUTURE PERSPECTIVES.REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 146. VOL. 146. ISSUE . P. 1 -53 | 214 | 72% | 311 |
6 | MONTANA, AM , BATALLA, C , (2009) THE RATIONAL DESIGN OF ANTICANCER PLATINUM COMPLEXES: THE IMPORTANCE OF THE STRUCTURE-ACTIVITY RELATIONSHIP.CURRENT MEDICINAL CHEMISTRY. VOL. 16. ISSUE 18. P. 2235 -2260 | 199 | 75% | 69 |
7 | JAMIESON, ER , LIPPARD, SJ , (1999) STRUCTURE, RECOGNITION, AND PROCESSING OF CISPLATIN-DNA ADDUCTS.CHEMICAL REVIEWS. VOL. 99. ISSUE 9. P. 2467-2498 | 163 | 55% | 1671 |
8 | STARHA, P , VANCO, J , TRAVNICEK, Z , (2017) PLATINUM COMPLEXES CONTAINING ADENINE-BASED LIGANDS: AN OVERVIEW OF SELECTED STRUCTURAL FEATURES.COORDINATION CHEMISTRY REVIEWS. VOL. 332. ISSUE . P. 1 -29 | 156 | 88% | 0 |
9 | GALANSKI, M , JAKUPEC, MA , KEPPLER, BK , (2005) UPDATE OF THE PRECLINICAL SITUATION OF ANTICANCER PLATINUM COMPLEXES: NOVEL DESIGN STRATEGIES AND INNOVATIVE ANALYTICAL APPROACHES.CURRENT MEDICINAL CHEMISTRY. VOL. 12. ISSUE 18. P. 2075-2094 | 131 | 81% | 340 |
10 | PABLA, N , DONG, Z , (2008) CISPLATIN NEPHROTOXICITY: MECHANISMS AND RENOPROTECTIVE STRATEGIES.KIDNEY INTERNATIONAL. VOL. 73. ISSUE 9. P. 994-1007 | 103 | 72% | 504 |
Classes with closest relation at Level 3 |